In the year ahead, investors should expect Big Pharma to have its wallet open. Total deal volume for the drug industry has reached $253 billion globally so far this year, according to Dealogic. The onset of the coronavirus pandemic, coupled with election-related uncertainty over future industry regulations meant fewer large deals were agreed upon. Also Read | The march of 2020 in 10 key long readsInvestors are expecting that to change, and for good reason. And while Big Pharma is always a popular target for politicians, the industry might get some political capital from having developed safe and effective Covid-19 vaccines in record time.

Source: Mint December 31, 2020 05:37 UTC